GeoVax Labs Investor Relations Material
Latest events
Q2 2025
GeoVax Labs
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from GeoVax Labs Inc
Access all reports
GeoVax Labs Inc is a biotechnology company focused on developing vaccines and immunotherapies for infectious diseases and cancer. The company utilizes its proprietary vaccine platforms to target viral and bacterial pathogens, as well as tumor-associated antigens. Its development pipeline includes both preventive and therapeutic candidates undergoing preclinical and clinical testing. GeoVax Labs Inc is headquartered in Smyrna, Georgia, and its shares are listed on the NASDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
GOVX
Country
🇺🇸 United States